KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.32 Cr |
What is the latest Consolidated Net Profit of KWALITY PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹24 Cr |
Mar2023 | ₹19 Cr |
Mar2022 | ₹120 Cr |
Mar2021 | ₹15 Cr |
Mar2020 | ₹8.32 Cr |
How is Consolidated Net Profit of KWALITY PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹24 Cr | 22.83 | |
Mar2023 | ₹19 Cr | -83.85 | |
Mar2022 | ₹120 Cr | 692.23 | |
Mar2021 | ₹15 Cr | 82.11 | |
Mar2020 | ₹8.32 Cr | - |
Compare Consolidated Net Profit of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹964.1 Cr | 1.4% | 25.6% | 75% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | 1.4% |
25.6% |
75% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses